Paraxanthine After 40

Paraxanthine is marketed as a cleaner, gentler version of caffeine. For people over 40, whose sleep, blood pressure and medicines are changing, the question is whether that claim holds up. Our editorial team reviews the evidence.

What paraxanthine is

Paraxanthine (1,7-dimethylxanthine) is the main breakdown product of caffeine. When you drink a cup of coffee, the liver enzyme CYP1A2 converts most of the caffeine into paraxanthine, which circulates in the blood and contributes to the stimulating effect we associate with coffee.

In recent years paraxanthine has been produced as a stand-alone ingredient and marketed in pre-workouts and focus supplements as a "smoother" alternative to caffeine. The pitch is that you get the alertness without some of the jitters, because you skip the parent compound and its other metabolites.

The idea is plausible, but the human evidence base is still small and much of it has been funded by companies that sell the ingredient. It is worth keeping that in mind when reading enthusiastic marketing.

For readers over 40, the question is less about peak performance and more about whether paraxanthine is a gentler, safer stimulant than caffeine given changes in sleep, blood pressure and medication that often come with age.

Why age changes the picture

From midlife onwards, several factors alter how people respond to stimulants. Sleep becomes lighter and more easily disrupted, so a late-afternoon dose of caffeine, or presumably paraxanthine, may have a bigger impact on sleep quality.

Blood pressure tends to rise with age, and stimulants can produce short-term increases. People with diagnosed hypertension, arrhythmias or anxiety disorders become more common in the over-40 population.

Hormonal changes matter too. Oestrogen-containing medicines, including some hormone replacement therapy, can slow caffeine clearance, and pregnancy slows it markedly. Smoking speeds it up; quitting slows it down again.

Finally, medicines that inhibit CYP1A2, such as fluvoxamine and ciprofloxacin, can greatly prolong caffeine's effect. How strongly such interactions apply to supplemental paraxanthine is not well studied, which is itself a reason for caution.

Caffeine versus paraxanthine: what we know

An early clinical pharmacology study by Benowitz and colleagues found that paraxanthine produced sympathomimetic effects, including raised blood pressure, broadly similar to caffeine. That does not support the idea that it is free of cardiovascular effects.

Animal toxicology work published by Purpura and colleagues did not reveal genotoxicity concerns. This is reassuring but cannot replace long-term human safety data.

Practical considerations for over-40s

If you are considering paraxanthine, a few principles apply regardless of age, and they matter more after 40:

• Count it as a stimulant, just like caffeine, and do not stack it with strong coffee or other pre-workouts.
• Avoid taking it in the afternoon or evening if your sleep is fragile.
• Check your blood pressure if you start any regular stimulant use.
• Speak to a pharmacist if you take antidepressants, antibiotics, heart medicines or hormone therapy.
• Check that the product is legally sold in the UK; new food ingredients without a history of consumption before 1997 require novel food authorisation.

For caffeine itself, the European Food Safety Authority considers intakes of up to 400 mg a day safe for most healthy adults and single doses up to about 200 mg unlikely to cause concern. There is no equivalent established reference for paraxanthine.

For many people over 40, a moderate amount of ordinary coffee, timed early in the day, will provide similar benefits with a much larger body of safety evidence behind it.

Who should avoid it

People with uncontrolled high blood pressure, arrhythmias, heart disease, anxiety or panic disorder, and those with significant insomnia should avoid paraxanthine and other stimulant supplements unless advised otherwise by a doctor.

Pregnant and breastfeeding women should not use it; NHS advice is to limit caffeine to 200 mg a day in pregnancy, and paraxanthine has not been studied in this group.

Anyone experiencing palpitations, chest pain, severe headache or dizziness after taking a stimulant should stop and seek medical advice.

Masters athletes subject to testing should note that caffeine is currently on WADA's monitoring programme rather than the prohibited list, but multi-ingredient products can contain banned stimulants, so batch-tested products are advisable.

Editorial conclusions

Paraxanthine is an interesting new ingredient with a sound biological rationale, but it is not a stimulant-free alternative to caffeine and its human evidence base remains thin. After 40, sleep, blood pressure and drug interactions should guide any decision.

For most people, a measured amount of coffee or caffeine early in the day remains the better-understood option.

If you have cardiovascular conditions or take regular medication, ask a pharmacist before using any stimulant product.

See also our articles on caffeine and sleep, pre-workout safety, and blood pressure in athletes.

References

1. Benowitz NL, Jacob P 3rd, Mayan H, Denaro C. Sympathomimetic effects of paraxanthine and caffeine in humans. Clin Pharmacol Ther. 1995;58(6):684–691.
2. Nehlig A. Interindividual differences in caffeine metabolism and factors driving caffeine consumption. Pharmacol Rev. 2018;70(2):384–411.
3. Guest NS, VanDusseldorp TA, Nelson MT, et al. International Society of Sports Nutrition position stand: caffeine and exercise performance. J Int Soc Sports Nutr. 2021;18(1):1.
4. EFSA Panel on Dietetic Products, Nutrition and Allergies. Scientific opinion on the safety of caffeine. EFSA J. 2015;13(5):4102.
5. Purpura M, Jäger R, Falk M. An assessment of mutagenicity, genotoxicity, acute-, subacute and subchronic oral toxicity of paraxanthine (1,7-dimethylxanthine). Food Chem Toxicol. 2021;158:112579.